Coho Partners LTD Decreased By $3.95 Million Its Amerisourcebergen Corp. (ABC) Stake; Cymabay Therapeutics (CBAY) SI Increased By 8.35%

June 21, 2017 - By Ellis Scott

Coho Partners Ltd decreased Amerisourcebergen Corp. (ABC) stake by 4.98% reported in 2016Q4 SEC filing. Coho Partners Ltd sold 50,627 shares as Amerisourcebergen Corp. (ABC)’s stock declined 1.76%. The Coho Partners Ltd holds 965,885 shares with $75.52 million value, down from 1.02M last quarter. Amerisourcebergen Corp. now has $20.59 billion valuation. The stock rose 1.66% or $1.54 reaching $94.79. About 319,740 shares traded. AmerisourceBergen Corp. (NYSE:ABC) has risen 18.80% since June 21, 2016 and is uptrending. It has outperformed by 2.10% the S&P500.

Cymabay Therapeutics Incorporated (NASDAQ:CBAY) had an increase of 8.35% in short interest. CBAY’s SI was 765,200 shares in June as released by FINRA. Its up 8.35% from 706,200 shares previously. With 161,200 avg volume, 5 days are for Cymabay Therapeutics Incorporated (NASDAQ:CBAY)’s short sellers to cover CBAY’s short positions. The SI to Cymabay Therapeutics Incorporated’s float is 3.07%. It is 0.00% or $0 reaching $5.09 per share. It is down 69.26% since June 21, 2016 and is uptrending. It has outperformed by 52.56% the S&P500.

CymaBay Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The company has market cap of $148.39 million. The Firm is focused on developing therapies to treat metabolic diseases, including serious rare and orphan diseases. It currently has negative earnings. The Company’s product candidates include Arhalofenate, MBX-8025 and MBX-2982.

Among 3 analysts covering Cymabay Therapeutics Inc (NASDAQ:CBAY), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Cymabay Therapeutics Inc had 7 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was initiated by Piper Jaffray on Tuesday, July 21 with “Overweight”. The rating was initiated by Roth Capital on Friday, July 1 with “Buy”. The firm has “Buy” rating by H.C. Wainwright given on Wednesday, March 30. H.C. Wainwright initiated the shares of CBAY in report on Tuesday, September 8 with “Buy” rating. On Monday, January 30 the stock rating was upgraded by H.C. Wainwright to “Buy”. H.C. Wainwright maintained the stock with “Neutral” rating in Wednesday, January 4 report. The company was downgraded on Wednesday, June 1 by H.C. Wainwright.

Among 17 analysts covering AmerisourceBergen (NYSE:ABC), 9 have Buy rating, 0 Sell and 8 Hold. Therefore 53% are positive. AmerisourceBergen had 36 analyst reports since July 27, 2015 according to SRatingsIntel. The rating was maintained by FBR Capital with “Mkt Perform” on Thursday, February 4. Leerink Swann upgraded it to “Outperform” rating and $9 target in Tuesday, January 17 report. The company was downgraded on Wednesday, January 6 by Raymond James. As per Tuesday, October 4, the company rating was upgraded by Avondale. As per Friday, October 2, the company rating was downgraded by Morgan Stanley. RBC Capital Markets maintained AmerisourceBergen Corp. (NYSE:ABC) rating on Wednesday, October 7. RBC Capital Markets has “Outperform” rating and $130 target. RBC Capital Markets maintained the stock with “Outperform” rating in Friday, February 5 report. The company was upgraded on Tuesday, August 25 by Zacks. The rating was initiated by Needham on Tuesday, April 4 with “Buy”. The company was downgraded on Thursday, August 27 by Zacks.